Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        

Generate Chart For    
    (Chart displayed below)
Rat Strains
{{sample.term}}
Measurement Methods
{{method.term}}
Age
{{ageRange}}
Experimental Conditions
     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord IDCondition 1Condition 2
8serum creatinine levelLOU/MWslmale0.76614mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)109775rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)
8serum creatinine levelLOU/MWslmale0.78761mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) 109776rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg)
8serum creatinine levelLOU/MWslmale0.70738mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 7 days)109777rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg) (for 7 days)
8serum creatinine levelLOU/MWslmale0.791mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 14 days)109778rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg) (for 14 days)
5serum creatinine levelLOU/MWslmale0.63054mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 42 days)109779rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg) (for 42 days)
3serum creatinine levelLOU/MWslmale0.57517mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 56 days)109780rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg) (for 56 days)
8serum creatinine levelLOU/MWslmale0.82942mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) 109781rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 mg/kg)
8serum creatinine levelLOU/MWslmale0.6893mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 7 days)109782rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 mg/kg) (for 7 days)
8serum creatinine levelLOU/MWslmale0.68139mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 14 days)109783rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 mg/kg) (for 14 days)
6serum creatinine levelLOU/MWslmale0.44861mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 42 days)109784rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 mg/kg) (for 42 days)
8serum creatinine levelLOU/MWslmale0.59438mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 mg/kg) (for 56 days)109785rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 mg/kg) (for 56 days)
7serum creatinine levelLOU/MWslmale0.76049mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg) 109786rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 mg/kg)
8serum creatinine levelLOU/MWslmale0.63732mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg) (for 7 days)109787rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 mg/kg) (for 7 days)
6serum creatinine levelLOU/MWslmale0.5876mg/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg) (for 14 days)109788rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 mg/kg) (for 14 days)
6serum creatinine levelLOU/MWslmale0.678mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109622rat IgM immunocytoma cells (1 x 10E4 cells)
6serum creatinine levelLOU/MWslmale0.58986mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 17 days)109623rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 17 days)
6serum creatinine levelLOU/MWslmale0.8136mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 33 days)109624rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 33 days)
2serum creatinine levelLOU/MWslmale0.6893mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 40 days)109625rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 40 days)
6serum creatinine levelLOU/MWslmale0.61359mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109626rat IgM immunocytoma cells (1 x 10E4 cells)
5serum creatinine levelLOU/MWslmale0.47008mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 33 days)109627rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 33 days)
4serum creatinine levelLOU/MWslmale0.565mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 47 days)109628rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 47 days)
6serum creatinine levelLOU/MWslmale0.63845mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109629rat IgM immunocytoma cells (1 x 10E4 cells)
5serum creatinine levelLOU/MWslmale1.43058mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (2 mg/kg) (for 17 days)109630rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (2 mg/kg) (for 17 days)
5serum creatinine levelLOU/MWslmale0.63732mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109631rat IgM immunocytoma cells (1 x 10E4 cells)
5serum creatinine levelLOU/MWslmale0.53336mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)109632rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)
2serum creatinine levelLOU/MWslmale0.57065mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 33 days)109633rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 33 days)
6serum creatinine levelLOU/MWslmale0.5537mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109634rat IgM immunocytoma cells (1 x 10E4 cells)
6serum creatinine levelLOU/MWslmale0.56839mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)109635rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)
4serum creatinine levelLOU/MWslmale0.59664mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 47 days)109636rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 47 days)
6serum creatinine levelLOU/MWslmale0.62715mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109637rat IgM immunocytoma cells (1 x 10E4 cells)
5serum creatinine levelLOU/MWslmale0.55822mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 17 days)109638rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 17 days)
6serum creatinine levelLOU/MWslmale0.54805mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109639rat IgM immunocytoma cells (1 x 10E4 cells)
4serum creatinine levelLOU/MWslmale0.71416mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)109640rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)
6serum creatinine levelLOU/MWslmale0.60455mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109641rat IgM immunocytoma cells (1 x 10E4 cells)
3serum creatinine levelLOU/MWslmale0.64749mg/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)109642rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)
8serum albumin levelLOU/MWslmale312g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)109760rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)
5serum albumin levelLOU/MWslmale219g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then vehicle control condition (1 ml/kg) (for 7 days)109761rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)vehicle control condition (1 ml/kg) (for 7 days)
8serum albumin levelLOU/MWslmale316g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 ml/kg) 109762rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 ml/kg)
8serum albumin levelLOU/MWslmale298g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 ml/kg) (for 7 days)109763rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 ml/kg) (for 7 days)
8serum albumin levelLOU/MWslmale310g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 ml/kg) (for 14 days)109764rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 ml/kg) (for 14 days)
5serum albumin levelLOU/MWslmale237g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 ml/kg) (for 42 days)109765rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 ml/kg) (for 42 days)
3serum albumin levelLOU/MWslmale254g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 ml/kg) (for 56 days)109766rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 ml/kg) (for 56 days)
8serum albumin levelLOU/MWslmale336g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 ml/kg) 109767rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 ml/kg)
8serum albumin levelLOU/MWslmale289g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 ml/kg) (for 7 days)109768rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 ml/kg) (for 7 days)
8serum albumin levelLOU/MWslmale273g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 ml/kg) (for 14 days)109769rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 ml/kg) (for 14 days)
7serum albumin levelLOU/MWslmale62g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 ml/kg) (for 42 days)109770rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 ml/kg) (for 42 days)
8serum albumin levelLOU/MWslmale15g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (1 ml/kg) (for 56 days)109771rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (1 ml/kg) (for 56 days)
7serum albumin levelLOU/MWslmale249g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 ml/kg) 109772rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 ml/kg)
8serum albumin levelLOU/MWslmale269g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 ml/kg) (for 7 days)109773rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 ml/kg) (for 7 days)
8serum albumin levelLOU/MWslmale40g/dlrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 ml/kg) (for 14 days)109774rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 ml/kg) (for 14 days)
6serum albumin levelLOU/MWslmale299g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109581rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale210g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then 0.9% sodium chloride solution (for 7 days)109582rat IgM immunocytoma cells (1 x 10E4 cells) 0.9% sodium chloride solution (for 7 days)
2serum albumin levelLOU/MWslmale195g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then 0.9% sodium chloride solution (for 10 days)109583rat IgM immunocytoma cells (1 x 10E4 cells) 0.9% sodium chloride solution (for 10 days)
6serum albumin levelLOU/MWslmale294g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109584rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale317g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 17 days)109585rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 17 days)
6serum albumin levelLOU/MWslmale323g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 25 days)109586rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 25 days)
6serum albumin levelLOU/MWslmale224g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 33 days)109587rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 33 days)
2serum albumin levelLOU/MWslmale175g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (0.5 mg/kg) (for 40 days)109588rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (0.5 mg/kg) (for 40 days)
6serum albumin levelLOU/MWslmale278g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109589rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale241g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 17 days)109590rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 17 days)
6serum albumin levelLOU/MWslmale201g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 25 days)109591rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 25 days)
6serum albumin levelLOU/MWslmale124g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 40 days)109592rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 40 days)
4serum albumin levelLOU/MWslmale96g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 47 days)109593rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 47 days)
6serum albumin levelLOU/MWslmale288g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109594rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale245g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (2 mg/kg) (for 7 days)109595rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (2 mg/kg) (for 7 days)
6serum albumin levelLOU/MWslmale87g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (2 mg/kg) (for 10 days)109596rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (2 mg/kg) (for 10 days)
6serum albumin levelLOU/MWslmale289g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109597rat IgM immunocytoma cells (1 x 10E4 cells)
5serum albumin levelLOU/MWslmale209g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposomes (for 7 days)109598rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposomes (for 7 days)
6serum albumin levelLOU/MWslmale208g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposomes (for 10 days)109599rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposomes (for 10 days)
5serum albumin levelLOU/MWslmale294g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109600rat IgM immunocytoma cells (1 x 10E4 cells)
5serum albumin levelLOU/MWslmale302g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)109601rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)
5serum albumin levelLOU/MWslmale265g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 25 days)109602rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 25 days)
2serum albumin levelLOU/MWslmale205g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 33 days)109603rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 33 days)
6serum albumin levelLOU/MWslmale268g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109604rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale301g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 17 days)109605rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 17 days)
6serum albumin levelLOU/MWslmale313g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 25 days)109606rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 25 days)
6serum albumin levelLOU/MWslmale285g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)109607rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)
5serum albumin levelLOU/MWslmale268g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 40 days)109608rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 40 days)
4serum albumin levelLOU/MWslmale265g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 47 days)109609rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 47 days)
6serum albumin levelLOU/MWslmale277g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109610rat IgM immunocytoma cells (1 x 10E4 cells)
5serum albumin levelLOU/MWslmale277g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 7 days)109611rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 7 days)
5serum albumin levelLOU/MWslmale289g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 10 days)109612rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 10 days)
6serum albumin levelLOU/MWslmale280g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109613rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale216g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposomes (for 7 days)109614rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposomes (for 7 days)
3serum albumin levelLOU/MWslmale207g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposomes (for 10 days)109615rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposomes (for 10 days)
6serum albumin levelLOU/MWslmale283g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109616rat IgM immunocytoma cells (1 x 10E4 cells)
4serum albumin levelLOU/MWslmale194g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)109617rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (0.5 mg/kg) (for 17 days)
6serum albumin levelLOU/MWslmale289g/dlrat IgM immunocytoma cells (1 x 10E4 cells) 109618rat IgM immunocytoma cells (1 x 10E4 cells)
6serum albumin levelLOU/MWslmale289g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 17 days)109619rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 17 days)
6serum albumin levelLOU/MWslmale244g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 25 days)109620rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 25 days)
3serum albumin levelLOU/MWslmale175g/dlrat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)109621rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 33 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth100%rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days)109481rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (1 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth90.8%rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 21 days)109482rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (1 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth78.5%rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (2 mg/kg) (for 21 days)109483rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (2 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth29.3%rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.25 mg/kg) (for 21 days)109487rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (0.25 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth66.7%rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 21 days)109488rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (0.5 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth89.8%rat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days)109489rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (1 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth-2.5%rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (0.25 mg/kg) (for 21 days)109490rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (0.25 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth63.6%rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (0.5 mg/kg) (for 21 days)109491rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (0.5 mg/kg) (for 21 days)
N/Amaximum tumor size decrease to pretreatment tumor size ratioLOU/Mboth95.8%rat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 21 days)109492rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (1 mg/kg) (for 21 days)
N/Atime from therapy-induced maximal immunocytoma size decrease to regrowth of tumor to a diameter of 10 mmLOU/Mboth4.6drat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 7 days)109497rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (0.5 mg/kg) (for 7 days)
N/Atime from therapy-induced maximal immunocytoma size decrease to regrowth of tumor to a diameter of 10 mmLOU/Mboth8.6drat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 7 days)109498rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (1 mg/kg) (for 7 days)
N/Atime from therapy-induced maximal immunocytoma size decrease to regrowth of tumor to a diameter of 10 mmLOU/Mboth6.8drat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (0.5 mg/kg) (for 7 days)109499rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (0.5 mg/kg) (for 7 days)
N/Atime from therapy-induced maximal immunocytoma size decrease to regrowth of tumor to a diameter of 10 mmLOU/Mboth7.2drat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 7 days)109500rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (1 mg/kg) (for 7 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth35drat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 35 days)109484rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (1 mg/kg) (for 35 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth28drat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 28 days)109485rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (1 mg/kg) (for 28 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth26.1drat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (2 mg/kg) (for 28 days)109486rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (2 mg/kg) (for 28 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth19.2drat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (0.5 mg/kg) (for 21 days)109493rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (0.5 mg/kg) (for 21 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth21.6drat IgM immunocytoma cells (1 x 10E4 cells) then cisplatin (1 mg/kg) (for 21 days)109494rat IgM immunocytoma cells (1 x 10E4 cells) cisplatin (1 mg/kg) (for 21 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth19.4drat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (0.5 mg/kg) (for 21 days)109495rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (0.5 mg/kg) (for 21 days)
N/Atime from start of drug therapy to immunocytoma regrowthLOU/Mboth20.2drat IgM immunocytoma cells (1 x 10E4 cells) then spiroplatin (1 mg/kg) (for 21 days)109496rat IgM immunocytoma cells (1 x 10E4 cells) spiroplatin (1 mg/kg) (for 21 days)
6change in body weight to initial body weight ratioLOU/MWslmale-8.1%rat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (1 mg/kg) (for 10 days)109575rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (1 mg/kg) (for 10 days)
6change in body weight to initial body weight ratioLOU/MWslmale-4.1%rat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days)109576rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days)
6change in body weight to initial body weight ratioLOU/MWslmale-3.2%rat IgM immunocytoma cells (1 x 10E4 cells) then positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days)109577rat IgM immunocytoma cells (1 x 10E4 cells) positively charged liposome-entrapped doxorubicin (1 mg/kg) (for 10 days)
6change in body weight to initial body weight ratioLOU/MWslmale10%rat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 28 days)109578rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (1 mg/kg) (for 28 days)
6change in body weight to initial body weight ratioLOU/MWslmale-40%rat IgM immunocytoma cells (1 x 10E4 cells) then doxorubicin (2 mg/kg) (for 14 days)109579rat IgM immunocytoma cells (1 x 10E4 cells) doxorubicin (2 mg/kg) (for 14 days)
6change in body weight to initial body weight ratioLOU/MWslmale-10%rat IgM immunocytoma cells (1 x 10E4 cells) then negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 14 days)109580rat IgM immunocytoma cells (1 x 10E4 cells) negatively charged liposome-entrapped doxorubicin (2 mg/kg) (for 14 days)
8subcutaneous tumor diameter measurementLOU/MWslmale15.8mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)109744rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)
8subcutaneous tumor diameter measurementLOU/MWslmale37.2mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then vehicle control condition (1 ml/kg) (for 28 days)109745rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)vehicle control condition (1 ml/kg) (for 28 days)
8subcutaneous tumor diameter measurementLOU/MWslmale37.2mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.06 mg/kg) (for 32 days)109746rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.06 mg/kg) (for 32 days)
8subcutaneous tumor diameter measurementLOU/MWslmale36.9mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.12 mg/kg) (for 32 days)109747rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.12 mg/kg) (for 32 days)
8subcutaneous tumor diameter measurementLOU/MWslmale32.6mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.25 mg/kg) (for 32 days)109748rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.25 mg/kg) (for 32 days)
8subcutaneous tumor diameter measurementLOU/MWslmale5mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (for 39 days)109749rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg) (for 39 days)
2subcutaneous tumor diameter measurementLOU/MWslmale0mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (0.5 mg/kg) (between 7.3 and 175 days)109750rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (0.5 mg/kg) (between 7.3 and 175 days)
8subcutaneous tumor diameter measurementLOU/MWslmale7.6mmrat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days) then doxorubicin (2 mg/kg) (for 32 days)109751rat IgM immunocytoma cells (0.01 x 10E6 cells) (for 18 days)doxorubicin (2 mg/kg) (for 32 days)
84subcutaneous tumor diameter measurementLOU/MWslmale18.1mmrat IgM immunocytoma cells (1 x 10E4 cells) 109570rat IgM immunocytoma cells (1 x 10E4 cells)
30subcutaneous tumor diameter measurementLOU/MWslmale20mmrat IgM immunocytoma cells (1 x 10E4 cells) 109571rat IgM immunocytoma cells (1 x 10E4 cells)
9post-treatment survival time from doxorubicin-treated IgM immunocytomaLOU/MWslmale8drat IgM immunocytoma cells (1 x 10E4 cells) (between 17 and 21 days) then 0.9% sodium chloride solution109572rat IgM immunocytoma cells (1 x 10E4 cells) (between 17 and 21 days)0.9% sodium chloride solution
10post-treatment survival time from doxorubicin-treated IgM immunocytomaLOU/MWslmale23drat IgM immunocytoma cells (1 x 10E4 cells) (between 17 and 21 days) then doxorubicin (2 mg/kg) 109573rat IgM immunocytoma cells (1 x 10E4 cells) (between 17 and 21 days)doxorubicin (2 mg/kg)
10post-treatment survival time from doxorubicin-treated IgM immunocytomaLOU/MWslmale40drat IgM immunocytoma cells (1 x 10E4 cells) (between 17 and 21 days) then negatively charged liposome-entrapped doxorubicin (2 mg/kg) 109574rat IgM immunocytoma cells (1 x 10E4 cells) (between 17 and 21 days)negatively charged liposome-entrapped doxorubicin (2 mg/kg)

Contact Us |  About Us |  Jobs at RGD